Therapeutic melanoma vaccine improves response rate, progression-free survival, study finds
Thursday, June 2, 2011 - 10:30
in Health & Medicine
A vaccine for one of the most lethal cancers, advanced melanoma, has improved response rate and progression-free survival for patients when combined with the immunotherapy drug Interleukin-2, according to new research.